Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption

MLA

Paul J. Coleman, et al. “Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption.” ChemMedChem, vol. 10, Dec. 2014, pp. 245–52. EBSCOhost, https://doi.org/10.1002/cmdc.201402393.

APA

Paul J. Coleman, Becky Nissley, Allen C. Templeton, Yunhui Wu, Rosa I. Sanchez, Jaume Balsells, Jay A. Grobler, Sophie-Dorothee Clas, Michael J. Hafey, Junying Wang, Abbas Walji, Qun Dang, Rebecca Nofsinger, Jing Li, Manuel de Lera Ruiz, Gene Chessen, John M. Sanders, Christopher T. John, Amrithraj Bennet, … Ronald D. Smith. (2014). Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption. ChemMedChem, 10, 245–252. https://doi.org/10.1002/cmdc.201402393

Chicago

Paul J. Coleman, Becky Nissley, Allen C. Templeton, Yunhui Wu, Rosa I. Sanchez, Jaume Balsells, Jay A. Grobler, et al. 2014. “Discovery of MK-8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption.” ChemMedChem 10 (December): 245–52. doi:10.1002/cmdc.201402393.